SCHEMBL26418599

SCHEMBL26418599

Cc1ccc(N2CCC3(CCNCC3)CC2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 8/20 0.69
USP2 O75604 7/20 0.69
ADRB1 P08588 4/20 0.67
GABRD O14764 2/20 0.56
GABRA1 P14867 2/20 0.56
GABRB1 P18505 2/20 0.56
GABRA5 P31644 2/20 0.56
GABRA3 P34903 2/20 0.56
GABRA2 P47869 2/20 0.56
GABRB2 P47870 2/20 0.56
GABRA4 P48169 2/20 0.56
TSHR P16473 9/20 0.53
CYP3A4 P08684 7/20 0.53
ALDH1A1 P00352 7/20 0.53
MAPK1 P28482 4/20 0.53
HSD17B10 Q99714 4/20 0.53
TP53 P04637 3/20 0.53
CYP1A2 P05177 3/20 0.53
DRD2 P14416 1/20 0.49
CYP2C19 P33261 6/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15235472 0.90 ADRB1 (0.58) CYP2D6USP2ADRB1GABRDGABRA1
SCHEMBL26407376 0.85 MAPT (0.56) CYP2D6USP2ADRB1GABRDGABRA1
SCHEMBL24123989 0.84 ADRB1 (0.58) CYP2D6USP2ADRB1GABRDGABRA1
SCHEMBL20842185 0.83 CYP2D6 (0.60) CYP2D6USP2ADRB1GABRDGABRA1
SCHEMBL19832328 0.83 ADRB1 (0.52) CYP2D6USP2ADRB1TSHRCYP3A4
SCHEMBL13050532 0.82 CYP2D6 (0.69) CYP2D6USP2ADRB1TSHRCYP3A4
SCHEMBL1778852 0.82 CYP2D6 (0.69) CYP2D6USP2ADRB1TSHRCYP3A4
SCHEMBL22537876 0.81 ADRB1 (0.50) CYP2D6USP2ADRB1TSHRCYP3A4
SCHEMBL26418600 0.81 ADRB1 (0.50) CYP2D6USP2ADRB1TSHRCYP3A4
SCHEMBL24123997 0.81 CYP2D6 (0.63) CYP2D6USP2ADRB1TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4169919-A1 PYRAZOLO[3,4-D]PYRIMIDINE-3-KETONE DERIVATIVE AS WEE-1 INHIBITOR Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2023-04-26 EP disclosed